These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 37192725)

  • 21. The humoral and cellular immune evasion of SARS-CoV-2 Omicron and sub-lineages.
    Xiang T; Wang J; Zheng X
    Virol Sin; 2022 Dec; 37(6):786-795. PubMed ID: 36427646
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A Heterologous Challenge Rescues the Attenuated Immunogenicity of SARS-CoV-2 Omicron BA.1 Variant in Syrian Hamster Model.
    Ma J; Liu X; Zhou M; Chen P; Chen R; Wang J; Zhu H; Wu K; Ye J; Zhang Y; Yuan Q; Tang Q; Yuan L; Cheng T; Guan Y; Xia N
    J Virol; 2023 Feb; 97(2):e0168422. PubMed ID: 36651747
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Phylogeny and evolution of SARS-CoV-2 during Delta and Omicron variant waves in India.
    Singh UB; Deb S; Rani L; Gupta R; Verma S; Kumari L; Bhardwaj D; Bala K; Ahmed J; Gaurav S; Perumalla S; Nizam M; Mishra A; Stephenraj J; Shukla J; Nayer J; Aggarwal P; Kabra M; Ahuja V; Chaudhry R; Sinha S; Guleria R
    J Biomol Struct Dyn; 2024 Jun; 42(9):4769-4781. PubMed ID: 37318006
    [TBL] [Abstract][Full Text] [Related]  

  • 24. SARS-CoV-2 nonstructural protein 6 from Alpha to Omicron: evolution of a transmembrane protein.
    Feng S; O'Brien A; Chen DY; Saeed M; Baker SC
    mBio; 2023 Aug; 14(4):e0068823. PubMed ID: 37477426
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Dual mechanism: Epigenetic inhibitor apabetalone reduces SARS-CoV-2 Delta and Omicron variant spike binding and attenuates SARS-CoV-2 RNA induced inflammation.
    Fu L; Gilham D; Stotz SC; Sarsons CD; Rakai BD; Tsujikawa LM; Wasiak S; Johansson JO; Sweeney M; Wong NCW; Kulikowski E
    Int Immunopharmacol; 2023 Apr; 117():109929. PubMed ID: 36857935
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Virological characteristics of the SARS-CoV-2 Omicron BA.2 spike.
    Yamasoba D; Kimura I; Nasser H; Morioka Y; Nao N; Ito J; Uriu K; Tsuda M; Zahradnik J; Shirakawa K; Suzuki R; Kishimoto M; Kosugi Y; Kobiyama K; Hara T; Toyoda M; Tanaka YL; Butlertanaka EP; Shimizu R; Ito H; Wang L; Oda Y; Orba Y; Sasaki M; Nagata K; Yoshimatsu K; Asakura H; Nagashima M; Sadamasu K; Yoshimura K; Kuramochi J; Seki M; Fujiki R; Kaneda A; Shimada T; Nakada TA; Sakao S; Suzuki T; Ueno T; Takaori-Kondo A; Ishii KJ; Schreiber G; ; Sawa H; Saito A; Irie T; Tanaka S; Matsuno K; Fukuhara T; Ikeda T; Sato K
    Cell; 2022 Jun; 185(12):2103-2115.e19. PubMed ID: 35568035
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Nucleopore Traffic Is Hindered by SARS-CoV-2 ORF6 Protein to Efficiently Suppress IFN-β and IL-6 Secretion.
    Gori Savellini G; Anichini G; Gandolfo C; Cusi MG
    Viruses; 2022 Jun; 14(6):. PubMed ID: 35746745
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The D405N Mutation in the Spike Protein of SARS-CoV-2 Omicron BA.5 Inhibits Spike/Integrins Interaction and Viral Infection of Human Lung Microvascular Endothelial Cells.
    Bugatti A; Filippini F; Messali S; Giovanetti M; Ravelli C; Zani A; Ciccozzi M; Caruso A; Caccuri F
    Viruses; 2023 Jan; 15(2):. PubMed ID: 36851546
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Antibody escape and cryptic cross-domain stabilization in the SARS-CoV-2 Omicron spike protein.
    Javanmardi K; Segall-Shapiro TH; Chou CW; Boutz DR; Olsen RJ; Xie X; Xia H; Shi PY; Johnson CD; Annapareddy A; Weaver S; Musser JM; Ellington AD; Finkelstein IJ; Gollihar JD
    Cell Host Microbe; 2022 Sep; 30(9):1242-1254.e6. PubMed ID: 35988543
    [TBL] [Abstract][Full Text] [Related]  

  • 30. SARS-CoV-2: Searching for the Missing Variants.
    Caputo E; Mandrich L
    Viruses; 2022 Oct; 14(11):. PubMed ID: 36366461
    [TBL] [Abstract][Full Text] [Related]  

  • 31. SARS-CoV-2 Omicron BA.1 Variant Infection of Human Colon Epithelial Cells.
    Antia A; Alvarado DM; Zeng Q; Casorla-Perez LA; Davis DL; Sonnek NM; Ciorba MA; Ding S
    Viruses; 2024 Apr; 16(4):. PubMed ID: 38675974
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Molecular insights into the SARS-CoV-2 Omicron variant from Bangladesh suggest diverse and continuous evolution.
    Afrin SZ; Sathi FA; Nooruzzaman M; Parvin R
    Virology; 2023 Oct; 587():109882. PubMed ID: 37757731
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comparative analysis of SARS-CoV-2 Omicron BA.2.12.1 and BA.5.2 variants.
    Ong CP; Ye ZW; Tang K; Liang R; Xie Y; Zhang H; Qin Z; Sun H; Wang TY; Cheng Y; Chu H; Chan JF; Jin DY; Yuan S
    J Med Virol; 2023 Jan; 95(1):e28326. PubMed ID: 36411262
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Nucleocapsid mutations in SARS-CoV-2 augment replication and pathogenesis.
    Johnson BA; Zhou Y; Lokugamage KG; Vu MN; Bopp N; Crocquet-Valdes PA; Kalveram B; Schindewolf C; Liu Y; Scharton D; Plante JA; Xie X; Aguilar P; Weaver SC; Shi PY; Walker DH; Routh AL; Plante KS; Menachery VD
    PLoS Pathog; 2022 Jun; 18(6):e1010627. PubMed ID: 35728038
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Analysis of SARS-CoV-2 Spike Protein Variants with Recombinant Reporter Viruses Created from a Bacmid System.
    Cordsmeier A; Jungnickl D; Herrmann A; Korn K; Ensser A
    Int J Mol Sci; 2023 May; 24(9):. PubMed ID: 37175863
    [TBL] [Abstract][Full Text] [Related]  

  • 36. SARS-CoV-2 variants evolve convergent strategies to remodel the host response.
    Bouhaddou M; Reuschl AK; Polacco BJ; Thorne LG; Ummadi MR; Ye C; Rosales R; Pelin A; Batra J; Jang GM; Xu J; Moen JM; Richards AL; Zhou Y; Harjai B; Stevenson E; Rojc A; Ragazzini R; Whelan MVX; Furnon W; De Lorenzo G; Cowton V; Syed AM; Ciling A; Deutsch N; Pirak D; Dowgier G; Mesner D; Turner JL; McGovern BL; Rodriguez ML; Leiva-Rebollo R; Dunham AS; Zhong X; Eckhardt M; Fossati A; Liotta NF; Kehrer T; Cupic A; Rutkowska M; Mena I; Aslam S; Hoffert A; Foussard H; Olwal CO; Huang W; Zwaka T; Pham J; Lyons M; Donohue L; Griffin A; Nugent R; Holden K; Deans R; Aviles P; Lopez-Martin JA; Jimeno JM; Obernier K; Fabius JM; Soucheray M; Hüttenhain R; Jungreis I; Kellis M; Echeverria I; Verba K; Bonfanti P; Beltrao P; Sharan R; Doudna JA; Martinez-Sobrido L; Patel AH; Palmarini M; Miorin L; White K; Swaney DL; Garcia-Sastre A; Jolly C; Zuliani-Alvarez L; Towers GJ; Krogan NJ
    Cell; 2023 Oct; 186(21):4597-4614.e26. PubMed ID: 37738970
    [TBL] [Abstract][Full Text] [Related]  

  • 37. In Silico Genome Analysis Reveals the Evolution and Potential Impact of SARS-CoV-2 Omicron Structural Changes on Host Immune Evasion and Antiviral Therapeutics.
    Chauhan D; Chakravarty N; Jeyachandran AV; Jayakarunakaran A; Sinha S; Mishra R; Arumugaswami V; Ramaiah A
    Viruses; 2022 Nov; 14(11):. PubMed ID: 36366559
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Mutational Analysis of Circulating Omicron SARS-CoV-2 Lineages in the Al-Baha Region of Saudi Arabia.
    Almalki SSR; Izhari MA; Alyahyawi HE; Alatawi SK; Klufah F; Ahmed WAM; Alharbi R
    J Multidiscip Healthc; 2023; 16():2117-2136. PubMed ID: 37529147
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Tracking SARS-CoV-2 Omicron diverse spike gene mutations identifies multiple inter-variant recombination events.
    Ou J; Lan W; Wu X; Zhao T; Duan B; Yang P; Ren Y; Quan L; Zhao W; Seto D; Chodosh J; Luo Z; Wu J; Zhang Q
    Signal Transduct Target Ther; 2022 Apr; 7(1):138. PubMed ID: 35474215
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Omicron Spike confers enhanced infectivity and interferon resistance to SARS-CoV-2 in human nasal tissue.
    Shi G; Li T; Lai KK; Johnson RF; Yewdell JW; Compton AA
    Nat Commun; 2024 Jan; 15(1):889. PubMed ID: 38291024
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.